Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Ascendis ADR News

    135,90 $ -0,75% -1,03 $
    In : 127,09 € | 26.04.24 21:59:50 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A14M6X
    ISIN: US04351P1012
    US-Symbol: ASND
    Typ: Aktie

    Ascendis ADR News

    07.01.24 - PR Newswire
    Specialised Therapeutics signs exclusive agreement with Ascendis Pharma A/S for distribution and commercialisation of three endocrinology therapies in Australia and select South-East Asia countries
    Specialised Therapeutics signs exclusive agreement with Ascendis Pharma A/S for distribution and commercialisation of three endocrinology therapies in Australia and select ...
    16.10.23 - PR Newswire
    ASCENDANT ANNOUNCES APPOINTMENT OF MR. VAL COETZEE AS DIRECTOR OF PROCESS ENGINEERING
    ASCENDANT ANNOUNCES APPOINTMENT OF MR. VAL COETZEE AS DIRECTOR OF PROCESS ENGINEERING PR Newswire
    05.09.23 - PR Newswire
    ASCENDANT RESOURCES ENTERS TENDER PHASE FOR MANDATED LEAD ARRANGER FOR ITS EXPORT CREDIT AGENCY SUPPORTED PROJECT FINANCING AT ITS LAGOA SALGADA PROJECT IN PORTUGAL
    ASCENDANT RESOURCES ENTERS TENDER PHASE FOR MANDATED LEAD ARRANGER FOR ITS EXPORT CREDIT AGENCY SUPPORTED PROJECT FINANCING AT ITS ...
    23.08.23 - PR Newswire
    Ascendant Resources Announces Results of Annual and Special Meeting of Shareholders
    Ascendant Resources Announces Results of Annual and Special Meeting of Shareholders PR Newswire
    01.08.23 - PR Newswire
    ASCENDANT RESOURCES EARNS 80% INTEREST IN THE LAGOA SALGADA PROJECT IN PORTUGAL AND FILES FEASIBILITY STUDY
    ASCENDANT RESOURCES EARNS 80% INTEREST IN THE LAGOA SALGADA PROJECT IN PORTUGAL AND FILES FEASIBILITY STUDY PR Newswire
    25.07.23 - PR Newswire
    ASCENDANT RESOURCES ANNOUNCES POST-TAX NPV8 OF US$147 MILLION AND 39% IRR FROM INITIAL FEASIBILITY STUDY AT ITS LAGOA SALGADA PROJECT IN PORTUGAL
    ASCENDANT RESOURCES ANNOUNCES POST-TAX NPV8 OF US$147 MILLION AND 39% IRR FROM INITIAL FEASIBILITY STUDY AT ITS LAGOA SALGADA PROJECT IN ...
    17.07.23 - PR Newswire
    ASCENDANT RESOURCES ANNOUNCES DATE OF ANNUAL SHAREHOLDERS' MEETING
    ASCENDANT RESOURCES ANNOUNCES DATE OF ANNUAL SHAREHOLDERS' MEETING PR Newswire
    05.07.23 - PR Newswire
    ASCENDANT ANNOUNCES POTENTIAL EXPORT CREDIT AGENCY SUPPORT FOR PROJECT FINANCE AT ITS LAGOA SALGADA PROJECT IN PORTUGAL
    ASCENDANT ANNOUNCES POTENTIAL EXPORT CREDIT AGENCY SUPPORT FOR PROJECT FINANCE AT ITS LAGOA SALGADA PROJECT IN PORTUGAL PR Newswire
    23.06.23 - PR Newswire
    ASCENDANT PROVIDES UPDATE FOR ITS LAGOA SALGADA PROJECT IN PORTUGAL
    ASCENDANT PROVIDES UPDATE FOR ITS LAGOA SALGADA PROJECT IN PORTUGAL PR Newswire
    02.05.23 - PR Newswire
    ASCENDANT RESOURCES CONFIRMS SALEABLE GRADE CONCENTRATES ACHIEVED FOR COPPER, LEAD AND ZINC WITH STRONG RECOVERIES AND PRECIOUS METAL CREDITS AT ITS LAGOA SALGADA VMS PROJECT, PORTUGAL
    ASCENDANT RESOURCES CONFIRMS SALEABLE GRADE CONCENTRATES ACHIEVED FOR COPPER, LEAD AND ZINC WITH STRONG RECOVERIES AND PRECIOUS METAL ...
    01.05.23 - PR Newswire
    Thinking about buying stock in Ascendis Pharma, IVERIC bio, Cardlytics, SoFi Technologies, or Elevation Oncology?
    Thinking about buying stock in Ascendis Pharma, IVERIC bio, Cardlytics, SoFi Technologies, or Elevation Oncology? PR Newswire
    22.04.23 - PR Newswire
    ASCENDIS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ascendis To Contact Him Directly To Discuss Their Options
    ASCENDIS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ascendis To Contact Him ...
    19.04.23 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ascendis Pharma A/S - ASND
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ascendis Pharma A/S - ASND PR Newswire
    17.04.23 - PR Newswire
    ASCENDANT PROVIDES AN UPDATE FOR ITS LAGOA SALGADA POLYMETALLIC PROJECT IN PORTUGAL
    ASCENDANT PROVIDES AN UPDATE FOR ITS LAGOA SALGADA POLYMETALLIC PROJECT IN PORTUGAL PR Newswire
    16.04.23 - PR Newswire
    ROSEN, A TOP RANKED LAW FIRM, Encourages Ascendis Pharma Investors to Inquire About Securities Class Action Investigation - ASND
    ROSEN, A TOP RANKED LAW FIRM, Encourages Ascendis Pharma Investors to Inquire About Securities Class Action Investigation - ASND PR Newswire
    10.04.23 - PR Newswire
    ASND EQUITY NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Ascendis Pharma Investors to Inquire About Securities Class Action Investigation - ASND
    ASND EQUITY NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Ascendis Pharma Investors to Inquire About Securities Class Action Investigation - ASND PR Newswire
    08.04.23 - PR Newswire
    ASCENDIS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ascendis To Contact Him Directly To Discuss Their Options
    ASCENDIS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ascendis To Contact Him ...
    15.10.22 - Small- & Micro Cap Investment
    18.02.2023 Biofrontera: Nanoemulsion – kleinste Teilchen, großes Potenzial
    Nanoemulsionen können sehr vielseitig in der Medizin angewandt werden – und eröffnen damit immer weitere Therapiemöglichkeiten. Das kommt Patientinnen und Patienten ...
    14.08.22 - Small- & Micro Cap Investment
    14.08.2022 Biofrontera: Nanoemulsion – kleinste Teilchen, großes Potenzial
    Nanoemulsionen können sehr vielseitig in der Medizin angewandt werden – und eröffnen damit immer weitere Therapiemöglichkeiten. Das kommt Patientinnen und Patienten ...

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »